Brazilian green propolis on Helicobacter pylori infection. A pilot clinical study

Helicobacter

Volumn 12, Issue 5, 2007, Pages 572-574

  Vaz Coelho, Luiz Gonzaga ^a,c   Ferreira Bastos, Esther Margarida Alves ^b   Resende, Clarissa Carvalho ^a   Paula E Silva, Celso Mirra ^a   Fernandes Sanches, Bruno Squarcio ^a   De Castro, Flávio José ^a   Moretzsohn, Luciana Dias ^a   Dos Santos Vieira, Washington Luiz ^a   Trindade, Osmar Reni ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

^c NONE   (Brazil)

Author keywords

Helicobacter pylori; Propolis; Therapy

Indexed keywords

ALCOHOL; BRAZILIAN GREEN PROPOLIS; CARBON 13; PROPOLIS; UNCLASSIFIED DRUG; UREASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; UREA BREATH TEST;

ANTI-INFECTIVE AGENTS; BRAZIL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROPOLIS; TREATMENT OUTCOME;

HELICOBACTER PYLORI;

EID: 34548153045     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00525.x     Document Type: Article

References (27)

1. Castaldo S, Capasso F. Propolis, an old remedy used in modern medicine. Fitoterapia 2002 73 : S1 6.
2. Santos FA, Bastos EM, Maia AB, et al. Brazilian propolis: physicochemical properties, plan origin and antibacterial activity on periodontopathogens. Phytother Res 2003 17 : 285 9.
3. Oliveira AC, Shinobu CS, Longhini R, Franco SL, Svidzinski TI. Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions. Mem Inst Oswaldo Cruz 2006 101 : 493 7.
4. Pascual C, Gonzalez R, Torricella R. Scavenging action of propolis extract against oxygen radicals. J Ethnopharmacol 1994 41 : 9 13.
5. Michaluart P, Masferrer JL, Carothers AM, et al. Inhibitory effects of caffeic acid phenethylester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in rat model of inflammation. Cancer Res 1999 59 : 2347 52.
6. Khalil ML. Biological activity of bee propolis in health and disease. Asian Pac J Cancer Prev 2006 7 : 22 31.
7. Pereira AS, Rodrigues F, Seixas MS, Aquino-Neto FR. Propolis: 100 years of research and future perspectives. Quim Nova 2002 25 : 321 6.
8. Velikova M, Bankova V, Sorkun K, Houcine S, Tsvetkova I, Kujumgiev A. Propolis from Mediterranean region: chemical composition and antimicrobial activity. Z Naturforsch 2000 55 : 790 3.
9. Koo H, Gomes BP, Rosalen PL, Ambrosano GM, Park YK, Cury JA. In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol 2000 45 : 141 8.
10. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 1999 64 : 235 40.
11. Drago L, Mombelli B, De vecchi E, Fassina MC, Tocalli L, Gismondo MR. In vitro antimicrobial activity of propolis dry extract. J Chemother 2000 12 : 390 5.
12. Banksota AH, Tezuka Y, Adnyana IK, et al. Hepatoprotective and anti-Helicobacter pylori activities of constituents from Brazilian propolis. Phytomedicine 2001 8 : 16 23.
13. Abdel-Latif MM, Windle HJ, Homasany BS, Sabra K, Kelleher D. Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells. Br J Pharmacol 2005 146 : 1139 47.
14. Nostro A, Cellini L, Di Bartolomeo S, et al. Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytother Res 2006 20 : 187 90.
15. Boyanova L, Gergova G, Nikolov R, et al. Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disk diffusion method. J Med Microbiol 2005 54 : 481 3.
16. Working party of the European Helicobacter pylori Study Group. Guidelines for clinical trials in Helicobacter pylori infection. Gut 1997 41 (Suppl. 2 S1 23.
17. Carson CF, Riley TV. Non-antibiotics therapies for infectious diseases. Commun Dis Intell 2003 27 (Suppl 143 6.
18. Salatino A, Teixeira EW, Negri G, Message D. Origin and chemical variation of Brazilian propolis. Evid Based Complement Alternat Med 2005 2 : 33 8.
19. Park YK, Alencar SM, Aguiar CL. Botanical origin and chemical composition of Brazilian propolis. J Agric Food Chem 2002 50 : 2502 6.
20. Nakajima Y, Shimazawa M, Mishima S, Hara H. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci 2007 80 : 370 7.
21. Paulino N, Teixeira C, Martins S, et al. Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis. Planta Med 2006 72 : 899 906.
22. Nostro A, Cellini L, Di Bartolomeo S, et al. Antibacterial effect of plant extracts against Helicobacter pylori. Phytother Res 2005 19 : 198 202.
23. Burdock GA. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 1998 36 : 347 63.
24. Hsu CY, Chiang WC, Chen WJ, Yuan A. Laryngeal edema and anaphalactic shock after topical propolis use for acute pharyngitis. Am J Emerg Med 2004 22 : 432 3.
25. Li YJ, Lin JL, Yang CW, Yu CC. Acute renal failure induced by a Brazilian variety of propolis. Am J Kidney Dis 2005 46 : e125 9.
26. 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies? Dig Liver Dis 2006 38 : 254 9.
27. 13C]-urea breath test for quantification of Helicobacter pylori infection. J Gastroenterol Hepatol 2000 15 : 161 7.